Ismn Stada

Isosorbide Mononitrate, the active ingredient in Ismn Stada, is a nitrate vasodilator presented as an oral dosage form for oral use. It is employed in the prophylaxis of angina pectoris to reduce myocardial oxygen demand in adult patients and improve exercise tolerance under physician supervision.

GNH USA supplies Ismn Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality assurance processes and regulatory compliance across EU and global markets, ensuring consistent product integrity and reliable supply chains.

Isosorbide Mononitrate is used in the management of coronary artery disease, specifically to prevent angina episodes. - Angina pectoris (chronic stable): reduces the frequency of chest‑pain attacks by lowering myocardial oxygen demand. - Exercise tolerance in angina patients: improves ability to perform physical activity without ischemic symptoms. - Secondary prevention after myocardial infarction: helps maintain stable coronary perfusion and limits recurrent angina.

Isosorbide Mononitrate may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: throbbing or pressure sensation, often transient. - Dizziness or light‑headedness: especially upon standing. - Flushing: warmth and redness of the face or neck. - Nausea: mild to moderate gastrointestinal upset. - Palpitations: awareness of heartbeat irregularities. - Hypotension: mild drop in blood pressure.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare occurrence of heart attack. - Life‑threatening arrhythmias: abnormal heart rhythms. - Anaphylactic reaction: rare severe allergic response. - Methemoglobinemia: abnormal hemoglobin causing cyanosis.

Before initiating therapy, clinicians should evaluate cardiovascular status and consider patient‑specific factors. - Assess blood pressure: ensure baseline values are adequate to tolerate vasodilation. - Review concomitant nitrate use: avoid additive hypotensive effects. - Monitor for drug‑induced headache: may require dose adjustment. - Caution in hepatic impairment: metabolism may be altered. - Store at room temperature: keep in the original container, protect from moisture and light.

Isosorbide Mononitrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): risk of profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause severe blood‑pressure drops. - Alcohol: potentiates vasodilatory effect and dizziness.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance blood‑pressure lowering, requiring dose titration. - Diuretics: combined effect on volume status may increase hypotension risk.